Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

1. pubmed.ncbi.nlm.nih.gov › 35368816Hypomagnesemia in the Cancer Patient - PubMed

   pubmed.ncbi.nlm.nih.gov › 35368816

   11 Νοε 2020 · Hypomagnesemia is a common medical problem that contributes to the morbidity and mortality of patients with cancer. This review summarizes magnesium physiology and highlights the mechanisms underlying magnesium disturbances due to cancer and cancer treatment.

   • Hypomagnesemia in Patients With Cancer: The Forgotten Ion

     We also examine the causes and mechanisms of magnesium...

2. journals.lww.com › kidney360 › fulltextHypomagnesemia in the Cancer Patient : Kidney360

   journals.lww.com › kidney360 › fulltext

   It is essential to anticipate, identify, and treat hypomagnesemia in patients with cancer. This review summarizes the mechanisms underlying the disturbances of Mg deficiency due to cancer and during cancer treatment.

3. www.seminarsinnephrology.org › article › S0270-9295(23)00057-8Hypomagnesemia in Patients With Cancer: The Forgotten Ion

   www.seminarsinnephrology.org › article › S0270-9295(23)00057-8

   20 Απρ 2023 · Hypomagnesemia, a deficiency of magnesium in the blood, is a frequent problem in cancer patients and can lead to severe symptoms and morbidity. In this review, we provide an in-depth analysis of the physiology and regulation of magnesium, and signs and symptoms of hypomagnesemia in cancer patients.

4. www.ncbi.nlm.nih.gov › books › NBK507261Magnesium and cancer: more questions than answers

   www.ncbi.nlm.nih.gov › books › NBK507261

   The last big question is whether knowledge about the connection between low Mg and cancer can be translated into useful approaches to prevent and treat cancer. Most of the data available suggest that Mg could be a chemo-preventive agent.

5. pubmed.ncbi.nlm.nih.gov › 37086496Hypomagnesemia in Patients With Cancer: The Forgotten Ion

   pubmed.ncbi.nlm.nih.gov › 37086496

   23 Απρ 2023 · We also examine the causes and mechanisms of magnesium imbalances in cancer patients, specifically focusing on cancer-specific therapies that can lead to hypomagnesemia. Finally, we provide updates on the management of hypomagnesemia, including oral and parenteral supplementation, as well as the role of drugs in cases that are resistant to ...

6. www.seminarsinnephrology.org › article › S0270-9295(23)00057-8Hypomagnesemia in Patients With Cancer: The Forgotten Ion

   www.seminarsinnephrology.org › article › S0270-9295(23)00057-8

   In this review, we provide an in-depth analysis of the physiology and regulation of magnesium, and signs and symptoms of hypomagnesemia in cancer patients. We also examine the causes and mechanisms of magnesium imbalances in cancer patients, specifically focusing on cancer-specific therapies that can lead to hypomagnesemia.

7. onlinelibrary.wiley.com › doi › fullOral magnesium supplements for cancer treatment‐induced...

   onlinelibrary.wiley.com › doi › full

   14 Δεκ 2021 · Optimal management of cancer treatment-induced hypomagnesemia (hMg) is not known. We assessed the feasibility of using a novel pragmatic clinical trials model to compare two commonly used oral Mg replacement strategies. Methods.